Psychotic symptoms prior or concomitant to diagnosis of multiple sclerosis: a systematic review of case reports and case series

References

• Camara-Lemarroy CR, Ibarra-Yruegas BE, Rodriguez-Gutierrez R, Berrios-Morales I, Ionete C, Riskind P. 2017. The varieties of psychosis in multiple sclerosis: a systematic review of cases. Mult Scler Relat Disord. 12:9–14. doi:10.1016/j.msard.2016.12.012
   PubMed Web of Science ®Google Scholar
• Charcot J. 1877. Lectures on the diseases of the nervous system, delivered at La Salpêtrière. Br Foreign Med Chir Rev 3:210–212.
   Google Scholar
• Compston A, Coles A. 2008. Multiple sclerosis. Lancet. 372(9648):1502–1517. doi:10.1016/S0140-6736(08)61620-7
   PubMed Web of Science ®Google Scholar
• Dazzan P, Murray RM. 2002. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry Suppl. 43:S50–S7.
   PubMedGoogle Scholar
• Feinstein A, Du Boulay G, Ron MA. 1992. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. Br J Psychiatry. 161:680–685. doi:10.1192/bjp.161.5.680
   PubMed Web of Science ®Google Scholar
• Ghaffar O, Feinstein A. 2007. The neuropsychiatry of multiple sclerosis: a review of recent developments. Curr Opin Psychiatry. 20(3):278–285. doi:10.1097/YCO.0b013e3280eb10d7
   PubMed Web of Science ®Google Scholar
• Honer WG, Hurwitz T, Li DK, Palmer M, Paty DW. 1987. Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Arch Neurol. 44(2):187–190. doi:10.1001/archneur.1987.00520140053017
   PubMedGoogle Scholar
• Howes OD, McCutcheon R, Agid O, De Bartolomeis A, Van Beveren NJM, Birnbaum ML, Bloomfield MAP, Bressan RA, Buchanan RW, Carpenter WT, et al. 2017. Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. Am J Psychiatry. 174(3):216–229. doi:10.1176/appi.ajp.2016.16050503.
   PubMed Web of Science ®Google Scholar
• Hummer TA, Francis MM, Vohs JL, Liffick E, Mehdiyoun NF, Breier A. 2018. Characterization of white matter abnormalities in early-stage schizophrenia. Early Interv Psychiatry. 12(4):660–668. doi:10.1111/eip.12359
   PubMed Web of Science ®Google Scholar
• Jones S, Howard L, Thornicroft G. 2008. 'Diagnostic overshadowing': worse physical health care for people with mental illness. Acta Psychiatr Scand. 118(3):169–171. doi:10.1111/j.1600-0447.2008.01211.x
   PubMed Web of Science ®Google Scholar
• Karadayi H, Arisoy O, Altunrende B, Boztas MH, Sercan M. 2014. The relationship of cognitive impairment with neurological and psychiatric variables in multiple sclerosis patients. Int J Psychiatry Clin Pract. 18(1):45–51. doi:10.3109/13651501.2013.845221
   PubMed Web of Science ®Google Scholar
• Kasama T, Maeoka A, Oguro N. 2016. Clinical features of neuropsychiatric syndromes in systemic lupus erythematosus and other connective tissue diseases. Clin Med Insights Arthritis Musculoskelet Disord. 9:1–8.
   PubMed Web of Science ®Google Scholar
• Kosmidis MH, Giannakou M, Messinis L, Papathanasopoulos P. 2010. Psychotic features associated with multiple sclerosis. Int Rev Psychiatry. 22(1):55–66. doi:10.3109/09540261003589612
   PubMed Web of Science ®Google Scholar
• Leonhard K. 1990. Classification of endogenous psychoses. Psychopathology. 23(4-6):191–341. doi: 10.1159/000284659. PMID: 2084768
   Google Scholar
• Lo Fermo S, Barone R, Patti F, Laisa P, Cavallaro TL, Nicoletti A, Zappia M. 2010. Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study. Mult Scler. 16(6):742–748. doi:10.1177/1352458510365157
   PubMed Web of Science ®Google Scholar
• Luque FA, Jaffe SL. 2007. Cerebrospinal fluid analysis in multiple sclerosis. Int Rev Neurobiol. 79:341–356. doi:10.1016/S0074-7742(07)79015-3
   PubMed Web of Science ®Google Scholar
• Lyoo IK, Seol HY, Byun HS, Renshaw PF. 1996. Unsuspected multiple sclerosis in patients with psychiatric disorders: a magnetic resonance imaging study. J Neuropsychiatry Clin Neurosci. 8:54–59.
   PubMed Web of Science ®Google Scholar
• McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, et al. 2001. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 50(1):121–127. doi:10.1002/ana.1032
   PubMed Web of Science ®Google Scholar
• McHugh MJ, McGorry PD, Yuen HP, Hickie IB, Thompson A, de Haan L, Mossaheb N, Smesny S, Lin A, Markulev C, et al. 2018. The ultra-high-risk for psychosis groups: evidence to maintain the status quo. Schizophr Res. 195:543–548. doi:10.1016/j.schres.2017.09.003
   PubMed Web of Science ®Google Scholar
• Marrie RA, Reingold S, Cohen J, Stuve O, Trojano M, Sorensen PS, Cutter G, Reider N. 2015. The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review. Mult Scler. 21(3):305–317. doi:10.1177/1352458514564487
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 339:b2535. doi:10.1136/bmj.b2535
   PubMed Web of Science ®Google Scholar
• Mueser KT, Bellack AS, Brady EU. 1990. Hallucinations in schizophrenia. Acta Psychiatr Scand. 82(1):26–29. doi:10.1111/j.1600-0447.1990.tb01350.x
   PubMed Web of Science ®Google Scholar
• Najjar S, Pearlman DM. 2015. Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res. 161(1):102–112. doi:10.1016/j.schres.2014.04.041.
   PubMed Web of Science ®Google Scholar
• Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. 2013. Neuroinflammation and psychiatric illness. J Neuroinflammation. 10:43.
   PubMed Web of Science ®Google Scholar
• Najjar S, Steiner J, Najjar A, Bechter K. 2018. A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis. J Neuroinflammation. 15(1):40. doi:10.1186/s12974-018-1067-y
   PubMedGoogle Scholar
• Patten SB, Svenson LW, Metz LM. 2005. Psychotic disorders in MS: population-based evidence of an association. Neurology. 65(7):1123–1125. doi:10.1212/01.wnl.0000178998.95293.29
   PubMed Web of Science ®Google Scholar
• Reiss JP, Sam D, Sareen J. 2006. Psychosis in multiple sclerosis associated with left temporal lobe lesions on serial MRI scans. J Clin Neurosci. 13(2):282–284. doi:10.1016/j.jocn.2005.02.017
   PubMed Web of Science ®Google Scholar
• Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, Kiene H, Helfand M, Altman DG, Sox H, et al. 2017. CARE guidelines for case reports: explanation and elaboration document. J Clin Epidemiol. 89:218–235. doi:10.1016/j.jclinepi.2017.04.026
   PubMed Web of Science ®Google Scholar
• Shah JL, Tandon N, Keshavan MS. 2013. Psychosis prediction and clinical utility in familial high-risk studies: selective review, synthesis, and implications for early detection and intervention. Early Interv Psychiatry. 7(4):345–360. doi:10.1111/eip.12054
   PubMed Web of Science ®Google Scholar
• Silveira C, Guedes R, Maia D, Curral R, Coelho R. 2019. Neuropsychiatric symptoms of multiple sclerosis: state of the art. Psychiatry Investig. 16(12):877–888. doi:10.30773/pi.2019.0106
   PubMed Web of Science ®Google Scholar
• Šimunović Filipčić I, Ivezić E, Jakšić N, Mayer N, Grah M, Rojnić Kuzman M, Bajić Z, Svab V, Herceg M, Filipčić I. 2020. Gender differences in early onset of chronic physical multimorbidities in schizophrenia spectrum disorder: Do women suffer more? Early Intervention in Psychiatry. 14(4):418–427. doi:10.1111/eip.12867
   PubMed Web of Science ®Google Scholar
• Stevens JR. 1988. Schizophrenia and multiple sclerosis. Schizophr Bull. 14(2):231–241. doi:10.1093/schbul/14.2.231
   PubMed Web of Science ®Google Scholar
• Tonna M, Ossola P, Marchesi C, Bettini E, Lasalvia A, Bonetto C, Lenzi J, Rucci P, Iozzino L, Cellini M, et al. 2019. Dimensional structure of first episode psychosis. Early Interv Psychiatry. 13(6):1431–1438. doi:10.1111/eip.12789
   PubMed Web of Science ®Google Scholar
• Toosy AT, Mason DF, Miller DH. 2014. Optic neuritis. Lancet Neurol. 13(1):83–99. doi:10.1016/S1474-4422(13)70259-X
   PubMed Web of Science ®Google Scholar
• Uguz F, Akpinar Z, Ozkan I, Tokgoz S. 2008. Mood and anxiety disorders in patients with multiple sclerosis. Int J Psychiatry Clin Pract. 12(1):19–24. doi:10.1080/13651500701330825
   PubMed Web of Science ®Google Scholar
• Varambally S, Venkatasubramanian G, Gangadhar BN. 2012. Neurological soft signs in schizophrenia - The past, the present and the future. Indian J Psychiatry. 54(1):73–80. doi:10.4103/0019-5545.94653
   PubMedGoogle Scholar
• Waters F, Fernyhough C. 2017. Hallucinations: a systematic review of points of similarity and difference across diagnostic classes. Schizophr Bull. 43(1):32–43. doi:10.1093/schbul/sbw132
   PubMed Web of Science ®Google Scholar
• Wozniak JR, Block EE, White T, Jensen JB, Schulz SC. 2008. Clinical and neurocognitive course in early-onset psychosis: a longitudinal study of adolescents with schizophrenia-spectrum disorders. Early Interv Psychiatry. 2(3):169–177. doi:10.1111/j.1751-7893.2008.00075.x
   PubMed Web of Science ®Google Scholar
• Zanetti MV, Schaufelberger MS, de Castro CC, Menezes PR, Scazufca M, McGuire PK, Murray RM, Busatto GF. 2008. White-matter hyperintensities in first-episode psychosis. Br J Psychiatry. 193(1):25–30. doi:10.1192/bjp.bp.107.038901
   PubMed Web of Science ®Google Scholar